3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
4
Phase 2
3
Phase EARLY_PHASE1
1
Phase 1
1
Status
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Multiple Myeloma
27
Breast Neoplasms
23
Neoplasms
22
Pancreatic Neoplasms
19
Prostatic Neoplasms
17
Glioma
17
Glioblastoma
16
Leukemia, Myeloid, Acute
15
Recurrence
14
Solid Tumor
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Lymphoma, Non-Hodgkin
12
Brain Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Lung Neoplasms
9
Triple Negative Breast Neoplasms
8
Lymphoma
8
Hematologic Neoplasms
8
Melanoma
7
Lymphoma, B-Cell
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Advanced Solid Tumors
7
Polycystic Ovary Syndrome
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Carcinoma, Hepatocellular
6
Stomach Neoplasms
5
Myelodysplastic Syndromes
5
Leukemia, Plasma Cell
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Recruiting
×
Chondrosarcoma
×
Clear all
NCT06645808
2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1
Recruiting
32 enrolled